Sabra Health Care REIT Inc
F:SBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sabra Health Care REIT Inc
F:SBC
|
US |
|
Donear Industries Ltd
NSE:DONEAR
|
IN |
|
China Shenhua Energy Co Ltd
F:IKFC
|
CN |
|
M
|
Masco Corp
F:MSQ
|
US |
|
Arcimoto Inc
OTC:FUVV
|
US |
|
Telefonaktiebolaget LM Ericsson
F:ERCA
|
SE |
|
D
|
DR Horton Inc
SWB:HO2
|
US |
|
Sunnova Energy International Inc
OTC:NOVAQ
|
US |
Wall St Price Targets
SBC Price Targets Summary
Sabra Health Care REIT Inc
According to Wall Street analysts, the average 1-year price target for SBC is 19.51 EUR with a low forecast of 17.14 EUR and a high forecast of 22.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SBC's stock price target?
Price Target
19.51
EUR
According to Wall Street analysts, the average 1-year price target for SBC is 19.51 EUR with a low forecast of 17.14 EUR and a high forecast of 22.27 EUR.
What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 17%.
